Back to Blog
Why Dove Medical Press?
Call for Papers: Addressing global differences in hepatocellular carcinoma risk factors and management strategies
Adie Chan on January 4, 2018 at 1:58 pm
We at Dove Medical Press are encouraging authors to submit papers for the Journal of Hepatocellular Carcinoma that address global diversity in HCC risk factors and their effect on outcomes. Although significant advances have been made in multidisciplinary and individualized screening and treatments for HCC, such sophisticated methods are relatively expensive and therefore remain beyond the reach of many patients in less economically developed countries where local resources and healthcare budget are limited. To address the global differences in treatment provision, the journal Editors are seeking to publish multidisciplinary clinical and translational studies, cost-effective screening and treatment strategies and consensus statements, including those which consider available local resources.
Authors interested in publishing country-specific guidelines and conference proceedings may be eligible for a discounted publication processing fee. Such requests will be assessed on a case-by-case basis. Please contact Dawn Hesson at firstname.lastname@example.org with your query prior to submission.
Submit your manuscript
Reasons to publish in the Journal of Hepatocellular Carcinoma
• Indexed in PubMed/PMC, ESCI, DOAJ, OAIster
• Open Access
• Rigorous peer review process
• Expert Editorial Board Members
The Journal of Hepatocellular Carcinoma is an international open access journal published by Dove Medical CPress (part of the Taylor & Francis Group). Editor in chief: Dr Ahmed Kaseb